Axa’s Loxo Oncology, Inc LOXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-61,900
| Closed | -$8.67M | – | 1437 |
|
|
2018
Q4 | $8.67M | Hold |
61,900
| – | – | 0.04% | 461 |
|
|
2018
Q3 | $10.6M | Sell |
61,900
-4,700
| -7% | -$790K | 0.04% | 469 |
|
|
2018
Q2 | $11.6M | Sell |
66,600
-36,964
| -36% | -$5.55M | 0.04% | 408 |
|
|
2018
Q1 | $11.9M | Buy |
103,564
+3,728
| +4% | +$397K | 0.05% | 390 |
|
|
2017
Q4 | $8.4M | Buy |
99,836
+2,201
| +2% | +$184K | 0.03% | 525 |
|
|
2017
Q3 | $8.99M | Sell |
97,635
-15,821
| -14% | -$1.23M | 0.04% | 470 |
|
|
2017
Q2 | $9.1M | Sell |
113,456
-55,925
| -33% | -$3.1M | 0.04% | 443 |
|
|
2017
Q1 | $7.13M | Sell |
169,381
-33,706
| -17% | -$1.39M | 0.03% | 516 |
|
|
2016
Q4 | $6.52M | Buy |
203,087
+4,148
| +2% | +$106K | 0.03% | 512 |
|
|
2016
Q3 | $5.21M | Sell |
198,939
-61,473
| -24% | -$1.61M | 0.02% | 561 |
|
|
2016
Q2 | $6.04M | Sell |
260,412
-10,688
| -4% | -$266K | 0.03% | 524 |
|
|
2016
Q1 | $7.41M | Sell |
271,100
-4,380
| -2% | -$91.7K | 0.03% | 461 |
|
|
2015
Q4 | $7.84M | Sell |
275,480
-11,470
| -4% | -$308K | 0.03% | 448 |
|
|
2015
Q3 | $5.02M | Buy |
286,950
+72,086
| +34% | +$1.41M | 0.02% | 569 |
|
|
2015
Q2 | $3.87M | Buy |
214,864
+71,170
| +50% | +$973K | 0.02% | 641 |
|
|
2015
Q1 | $1.79M | Buy |
143,694
+10,149
| +8% | +$126K | 0.01% | 827 |
|
|
2014
Q4 | $1.57M | Buy |
133,545
+8,545
| +7% | +$99.5K | 0.01% | 856 |
|
|
2014
Q3 | $1.64M | Buy |
+125,000
| New | +$1.62M | 0.01% | 790 |
|
Other funds holding LOXO
Axa's LOXO Position: Q1 2019 in Review
Axa sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 61,900 shares — an estimated $8.67M sold.
Axa first reported a position in LOXO in Q3 2014 and held it in 18 quarters. The position peaked at $11.9M in Q1 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.
- Axa reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
- Axa sold 61,900 Loxo Oncology, Inc shares in Q1 2019, an estimated $8.67M.
- Axa first reported a position in Loxo Oncology, Inc in Q3 2014 and held it in 18 quarters.
- Axa's Loxo Oncology, Inc position peaked at $11.9M in Q1 2018.
- 1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.
Based on Axa's 13F filing for Q1 2019, filed 14 May 2019.